Prof. Dr. Jan G. Hengstler
Monika Turajski
Ardeystr. 67
44139 Dortmund

Dr. Wiebke Albrecht

Wissenschaftliche Mitarbeiterin

Hier finden Sie die Publikationen ab 2010, die am IfADo entstanden sind.

Comparative metabolism of aflatoxin B1 in mouse, rat and human primary hepatocytes using HPLC-MS/MS. Arch Toxicol 97: 3179-3196 (2023)
PBTK modeling of the pyrrolizidine alkaloid retrorsine to predict liver toxicity in mouse and rat. Arch Toxicol 97: 1319–1333 (2023)
Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56: 1578-1595.e8 (2023)
The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds. Chem Biol Interact 351: 109728 (2022) (16 pp)
Influence of bile acids on the cytotoxicity of chemicals in cultivated human hepatocytes. Toxicol In Vitro 81: 105344 (2022)
Stimulation of de novo glutathione synthesis by nitrofurantoin for enhanced resilience of hepatocytes. Cell Biol Toxicol 38: 847-864 (2022)
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay. Toxicol Lett 368: 33-46 (2022)
Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity. Arch Toxicol 96: 2967–2981 (2022)
Comparing in vitro human liver models to in vivo human liver using RNA-Seq. Arch Toxicol 95: 573–589 (2021)
Subcellular spatio-temporal intravital kinetics of aflatoxin B1 and ochratoxin A in liver and kidney. Arch Toxicol 95: 2163-2177 (2021)
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods. Arch Toxicol 94: 2435-2461 (2020)
Hepatotoxicity of anesthetic gases. (Letter to the editor). EXCLI J 19: 1052-1053 (2020)
Which concentrations are optimal for in vitro testing? (Letter to the editor). EXCLI J 19: 1172-1173 (2020)
Handling deviating control values in concentration-response curves. Arch Toxicol 94: 3787–3798 (2020)
Highlight report: Role of PD-L1 in never-smokers. EXCLI J 18: 439-441 (2019)